Antibody and CD8+ T Cell Responses: How the Delta Variant Evades Immunity?

SARS-CoV-2 vaccines have reduced efficiency against variants of concern. Find out how antibody and T cell responses are affected by variant associated mutations.

Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines

Frontiers In Silico Analysis Predicts a Limited Impact of SARS-CoV-2 Variants on CD8 T Cell Recognition

State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation

Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron

How Immunity Generated from COVID-19 Vaccines Differs from an Infection – NIH Director's Blog

CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study

The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity, Virology Journal

Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine

Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants

JCI - SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals